Lenz & Staehelin advised SK Telecom on all Swiss law aspects, along with lead counsel Lee&Ko and US law counsel White and Case. SK Telecom, a...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin assisted Unigestion on all legal aspects of the process. Unigestion and Kepler Cheuvreux have entered into a strategic partnership to establish a joint...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Asceneuron in its Series C financing. Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin has advised Volumina Medical in this financing round. Volumina Medical, a clinical stage MedTech company developing novel biomaterials for dermatology and plastic surgery,...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Transmutex on all legal matters. Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20M in the extension...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Asceneuron in this transaction. Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron have announced the signing of a licensing...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Gyrus Capital in this transaction, alongside with Chiomenti (Italian law) and Wolf Theiss (Albanian law). Consulcesi and Falcon Industrial was advised by...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin has advised EBU on the deal. In June 2022, the European Space Agency (ESA) and the European Broadcasting Union (EBU) entered into an...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised beqom SA in this transaction, while Walkers and Weil, Gotshal & Manges LLP assisted Sumeru Equity Partners. beqom, a company sponsored inter...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised the selling shareholders in this transaction. Freshfields Bruckhaus Deringer LLP and Bär & Karrer advised ZAPI Group on the deal. Forestay Capital...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Essential Pharma in this transaction. Essential Pharma, a portfolio company of Gyrus Capital, has acquired on December 8, 2021, the worldwide rights...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Carlyle in this transaction, alongside Linklaters and Latham & Watkins. Paul Hastings advised Astorg. Jeausserand Audouard advised the management of AutoForm. The...
You must be a Standard 1 Year member to access this content.
